254 related articles for article (PubMed ID: 22110708)
1. Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer.
Sabatier R; Finetti P; Adelaide J; Guille A; Borg JP; Chaffanet M; Lane L; Birnbaum D; Bertucci F
PLoS One; 2011; 6(11):e27656. PubMed ID: 22110708
[TBL] [Abstract][Full Text] [Related]
2. Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis--A short Report.
You Y; Li H; Qin X; Ran Y; Wang F
Cell Oncol (Dordr); 2016 Feb; 39(1):89-95. PubMed ID: 26631111
[TBL] [Abstract][Full Text] [Related]
3. Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo.
Li LW; Yu XY; Yang Y; Zhang CP; Guo LP; Lu SH
Int J Cancer; 2009 Oct; 125(7):1505-13. PubMed ID: 19521989
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary preconditioning, injury, and inflammation modulate expression of the candidate tumor suppressor gene ECRG4 in lung.
Kao S; Shaterian A; Cauvi DM; Dang X; Chun HB; De Maio A; Costantini TW; Coimbra R; Eliceiri BP; Baird A
Exp Lung Res; 2015 Apr; 41(3):162-72. PubMed ID: 25513848
[TBL] [Abstract][Full Text] [Related]
5. ECRG4 acts as a tumor suppressor and as a determinant of chemotherapy resistance in human nasopharyngeal carcinoma.
You Y; Yang W; Qin X; Wang F; Li H; Lin C; Li W; Gu C; Zhang Y; Ran Y
Cell Oncol (Dordr); 2015 Jun; 38(3):205-14. PubMed ID: 25707757
[TBL] [Abstract][Full Text] [Related]
6. Expression of ECRG4 is associated with lower proliferative potential of esophageal cancer cells.
Matsuzaki J; Torigoe T; Hirohashi Y; Tamura Y; Asanuma H; Nakazawa E; Saka E; Yasuda K; Takahashi S; Sato N
Pathol Int; 2013 Aug; 63(8):391-7. PubMed ID: 23957914
[TBL] [Abstract][Full Text] [Related]
7. The candidate tumor suppressor gene ECRG4 inhibits cancer cells migration and invasion in esophageal carcinoma.
Li L; Zhang C; Li X; Lu S; Zhou Y
J Exp Clin Cancer Res; 2010 Oct; 29(1):133. PubMed ID: 20937111
[TBL] [Abstract][Full Text] [Related]
8. Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
Mori Y; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Kurehara H; Mori R; Tomoda K; Ogawa R; Katada T; Harata K; Fujii Y
Oncol Rep; 2007 Oct; 18(4):981-5. PubMed ID: 17786363
[TBL] [Abstract][Full Text] [Related]
9. ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.
Tang GY; Tang GJ; Yin L; Chao C; Zhou R; Ren GP; Chen JY; Zhang W
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30918105
[TBL] [Abstract][Full Text] [Related]
10. ESPL1 is a candidate oncogene of luminal B breast cancers.
Finetti P; Guille A; Adelaide J; Birnbaum D; Chaffanet M; Bertucci F
Breast Cancer Res Treat; 2014 Aug; 147(1):51-9. PubMed ID: 25086634
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase-1 mRNA expression in human breast cancer: a meta-analysis.
Gonçalves A; Finetti P; Sabatier R; Gilabert M; Adelaide J; Borg JP; Chaffanet M; Viens P; Birnbaum D; Bertucci F
Breast Cancer Res Treat; 2011 May; 127(1):273-81. PubMed ID: 21069454
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of ECRG4 is associated with malignant properties and of prognostic importance in human gastric cancer.
You Y; Hu S
Cancer Biomark; 2022; 34(1):55-66. PubMed ID: 34657878
[TBL] [Abstract][Full Text] [Related]
13. ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma.
Götze S; Feldhaus V; Traska T; Wolter M; Reifenberger G; Tannapfel A; Kuhnen C; Martin D; Müller O; Sievers S
BMC Cancer; 2009 Dec; 9():447. PubMed ID: 20017917
[TBL] [Abstract][Full Text] [Related]
14. ECRG4 as a novel tumor suppressor gene inhibits colorectal cancer cell growth in vitro and in vivo.
Cai Z; Liang P; Xuan J; Wan J; Guo H
Tumour Biol; 2016 Jul; 37(7):9111-20. PubMed ID: 26762416
[TBL] [Abstract][Full Text] [Related]
15. The candidate tumor suppressor gene Ecrg4 as a wound terminating factor in cutaneous injury.
Shaterian A; Kao S; Chen L; DiPietro LA; Coimbra R; Eliceiri BP; Baird A
Arch Dermatol Res; 2013 Mar; 305(2):141-9. PubMed ID: 22899245
[TBL] [Abstract][Full Text] [Related]
16. Cell surface localization and release of the candidate tumor suppressor Ecrg4 from polymorphonuclear cells and monocytes activate macrophages.
Baird A; Coimbra R; Dang X; Lopez N; Lee J; Krzyzaniak M; Winfield R; Potenza B; Eliceiri BP
J Leukoc Biol; 2012 May; 91(5):773-81. PubMed ID: 22396620
[TBL] [Abstract][Full Text] [Related]
17. Downregulated ECRG4 is correlated with lymph node metastasis and predicts poor outcome for nasopharyngeal carcinoma patients.
Chen JY; Wu X; Hong CQ; Chen J; Wei XL; Zhou L; Zhang HX; Huang YT; Peng L
Clin Transl Oncol; 2017 Jan; 19(1):84-90. PubMed ID: 27119734
[TBL] [Abstract][Full Text] [Related]
18. Downregulated ECRG4 is associated with poor prognosis in renal cell cancer and is regulated by promoter DNA methylation.
Luo L; Wu J; Xie J; Xia L; Qian X; Cai Z; Li Z
Tumour Biol; 2016 Jan; 37(1):1121-9. PubMed ID: 26276361
[TBL] [Abstract][Full Text] [Related]
19. [Expression and function of ECRG4 in hepatocellular carcinoma].
Chao C; Lai Q; Luo T; Tang G; Zhou R; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):486-9. PubMed ID: 26705039
[TBL] [Abstract][Full Text] [Related]
20. A novel tumor suppressor gene ECRG4 interacts directly with TMPRSS11A (ECRG1) to inhibit cancer cell growth in esophageal carcinoma.
Li LW; Li YY; Li XY; Zhang CP; Zhou Y; Lu SH
BMC Cancer; 2011 Feb; 11():52. PubMed ID: 21288367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]